Objectives The purpose of this study was to examine the perspectives of primary care physicians in Texas around vaccine acceptance and potential patient barriers to vaccination. National surveys have shown fluctuating levels of acceptance for COVID-19 vaccination, and primary care physicians could play a crucial role in increasing vaccine uptake.
Design This study employed a cross-sectional anonymous survey design to collect data using an online questionnaire. Participants were asked about vaccination practices and policies at their practice site, perceptions of patient and community acceptance and confidence in responding to patient vaccine concerns.
Setting From November 2020 to January 2021, family medicine physicians and paediatricians completed an online questionnaire on COVID-19 vaccination that was distributed by professional associations.
Participants The survey was completed by 573 practising physicians, the majority of whom identified as family medicine physicians (71.0%) or paediatricians (25.7%), who are currently active in professional associations in Texas.
Results About three-fourths (74.0%) of participants reported that they would get the vaccine as soon as it became available. They estimated that slightly more than half (59.2%) of their patients would accept the vaccine, and 67.0% expected that the COVID-19 vaccine would be accepted in their local community. The majority of participants (87.8%) reported always, almost always or usually endorsing vaccines, including high levels of intention to recommend COVID-19 vaccination (81.5%). Participants felt most confident responding to patient concerns related to education about vaccine types, safety and necessity and reported least confidence in responding to personal or religious objections to COVID-19 vaccination.
Conclusions The majority of the physicians surveyed stated that they would receive the COVID-19 vaccination when it was available to them and were confident in their ability to respond to patient concerns. With additional education, support and shifting COVID-19 vaccinations into primary care settings, primary care physicians can use the trust they have built with their patients to address vaccine hesitancy and potentially increase acceptance and uptake.
- vaccination refusal
- family medicine
Data availability statement
No data are available.
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
What are the perspectives of primary care physicians and pediatricians in Texas regarding COVID-19 vaccine acceptance and patient barriers to vaccination?
Vaccine acceptance was high among primary care physicians with the majority of the participants stating they would receive the COVID-19 vaccine when available. Physicians were highly confident that they could address patient concerns regarding receipt of the vaccine. However, the vast majority of participants reported that they disagreed with dismissing a patient for refusing the COVID-19 vaccine.
Primary care physicians are in a unique position to address COVID-19 vaccine hesitancy and with additional training and support may be able to positively impact vaccination rates.
With emergency use authorisation for COVID-19 vaccines approved in December 2020, there is hope that the virus will become more controlled and a return to normalcy can be achieved. Essential to this goal is vaccinating enough of the population to achieve herd immunity, currently estimated at ≥80% of individuals in the USA.1 However, this concept of achieving heard immunity is changing in respect to COVID-19 due to issues of vaccine hesitancy and uptake and may be unachievable, which is leading some to reorient towards reaching a reasonable level of ‘normalcy’.2 The number of Americans willing to receive the vaccination fluctuated throughout 2020, from as high as 72% in May to 60% in December.3 A recently published (February 2021) systematic review reported a lower acceptance rate (56.9%), indicating that 3 months of vaccine delivery did not result in higher potential uptake.4 COVID-19 vaccine uptake may especially be harder among minority groups (eg, African-Americans) who experience more health inequities.5
To reach normalcy in the USA, all of those who report that they will accept the vaccine will have to do so, and a significant number of those who are vaccine hesitant will have to be motivated to vaccinate. Vaccine confidence and acceptance are largely predicated on trust in the safety and efficacy of the vaccine as well as in healthcare personnel, institutions and public and government officials who shape policies around vaccine dissemination and communication.6 Evidence-based and novel strategies are needed to increase vaccine acceptance, especially in those communities with historical distrust of healthcare professionals or stringent antivaccination beliefs.7 For example, Hildreth and Alcendor8 suggested a multimedia approach using social media, flyers, pamphlets and radio commentaries in multiple languages in order to reach minority groups in the USA. They also propose the use of virtual town halls with community leaders in order to address questions that the general public might have about the COVID-19 vaccine.8
A sizeable body of literature demonstrates that healthcare clinician recommendation is one of the most important factors in decreasing vaccine hesitancy and improving vaccine confidence, thereby improving vaccine uptake.9 10 This finding is borne out in two recent national survey of US adult acceptance of a COVID-19 vaccine.7 11 In the study by Head and colleagues, almost a quarter of respondents (n=739) reported that they would be more likely to receive the vaccine if their healthcare provider recommended it.11 In a national study of 672 participants, the majority of respondents identified “their own physician” as the most reliable source of information about COVID-19.7 It is important to note that vaccine hesitancy in parents when concerning childhood vaccinations has been linked being uncertain on whether they trust their paediatrician and to thoughts that their physician has not provided adequate information on vaccines.12 13
Undoubtedly, many patients will take the vaccine without any need for education, information or encouragement, but the novelty of the COVID-19 virus and vaccine technologies, as well as the speed of development, have the potential to introduce new barriers to vaccination. Furthermore, given that none of the initial vaccine trials enrolled children or pregnant women, and these groups tend to have higher incidences of vaccine hesitancy than the general population,14 15 primary care physicians (PCPs) will be crucial in providing accurate information and addressing patient concerns as the US approaches future phases of vaccine candidacy.16 However, while a few studies have gauged healthcare clinician acceptance of COVID-19 vaccines in general,17 18 no studies to date have explored the perspectives of PCPs on providing the vaccine to patients, anticipated acceptance by their patient population or the sources of hesitancy and concern that they are preparing to address. It is important to note, unless indicated, the authors are including paediatricians as PCPs based on definitions provided by the American Academy of Family Physicians.16
In order to gain insight into these factors, we surveyed paediatricians and family medicine physicians in Texas. Our objective was to understand PCPs’ experiences with COVID-19, their knowledge and willingness to receive the COVID-19 vaccines, their perspectives on their patients’ hesitancy to receive the vaccine and their willingness and reasons for dismissing a patient who refuses the COVID-19 vaccine.
Participants and procedures
This cross-sectional study consisted of an online questionnaire that was disseminated to a combined total of 8364 family medicine physicians and paediatricians across Texas. Two professional associations, the Texas Academy of Family Physicians19 and the Texas Pediatric Society,20 were contacted and agreed to distribute the questionnaire to all active members via email from 20 November 2020 to 31 January 2021. It is important to note, during this time, two mRNA vaccines for COVID-19 were approved for emergency use authorisation for adults.21 The professional associations sent an email containing the study description, contact information and a link to the questionnaire. Data were collected and stored using Research Electronic Data Capture, a web-based software used to aid research studies in securing and storing data.22 23 Participants were not incentivised and were given the option to skip questions that they did not want to answer. Responses to the questionnaire were anonymous.
Inclusion and exclusion criteria
The only inclusion criteria was that all participants had to be active members of one of the two professional associations.
The questionnaire used in this study was developed by the investigators to assess the perspectives of the physicians regarding COVID-19 vaccination. In addition to background and demographic questions, we asked participants about their medical training, practice characteristics, and patient population. Participants were also asked about vaccination practices at their site, including the age ranges that they vaccinate, vaccine endorsement frequency and dismissal policies (ie, polices related to discontinuing medical care of a patient) related to patient vaccine hesitancy or refusal. To assess vaccine intentions, participants (ie, physicians) were asked if and when they would accept vaccination for COVID-19. They were also asked to identify potential types of COVID-19 vaccines (eg, viral vector), estimate acceptance of COVID-19 vaccines by their patients and in their community. Finally, participants were asked to rate their confidence in responding to concerns related to delaying or refusing COVID-19 vaccinations using a 10-point Likert scale,24 a psychometric method used to assess the attitudes and motivations of individuals.24 Given that all questions were developed by the investigators specifically for this project and the recent onset of COVID-19, the questionnaire was not validated nor piloted prior to this study.
Responses to questions were summarised using descriptive statistics using SPSS V.26.25 Percentages and means with SDs (when applicable) were reported for each response.
Of the 676 individuals who opened the questionnaire, 103 did not complete any questions and were excluded from the data analysis. In total, 573 participants were included in the final sample.
A description of participants (n=573) and their practice setting are presented in table 1. About 3/4 (71.0%) of the sample were family medicine physicians. Slightly more than half of the sample was white (59.3%), and about 10% were of Hispanic ethnicity. The most common religion among participants was Christianity of some type (55%). The type, size and location of clinical practice settings were quite diverse.
Experiences with vaccines in patients
Participants’ experiences with patient vaccination are presented in table 2. Depending on the patient age group, from about 1/2 to 2/3 of participants reported that they provide vaccines to their patients in their practice. The majority of participants (87.8%) reported that they usually, always, or almost always endorse vaccines with their patients.
COVID-19 vaccination expectations
Data on COVID-19 vaccination expectations are presented in table 3. About 2/3 (65.6%) of participants were able to correctly identify the type of vaccine expected to be out soon as an RNA vaccine. Participants anticipated that over half (59.2%) of patients in their practice would accept the COVID-19 vaccine, and about 2/3 (67.0%) thought that the vaccine would be accepted in their local community. Three-fourths (74.0%) of participants indicated that they would get the vaccine as soon as it was available with only about 6% reporting that they would not get or were unsure if they would get the vaccine.
COVID-19 vaccine and patient dismissal practices
As noted in table 4, only a small number of participants (8.9%) indicated that they thought that physicians should dismiss parents or patients who refuse the COVID-19 vaccine. The most commonly cited potential reasons for dismissal were concern for either the safety of other patients (47.6%) or clinical staff (40.8%). In terms of rating their own confidence to respond to patients and parents who want to delay or refuse the vaccine, highest average confidence ratings were for issues related to patient education: belief that the vaccine would cause illness (8.12), not knowing enough about the vaccine (8.08) or thinking that it was not needed or necessary (7.92). Participants reported lowest average ratings of confidence for responding to parents or patients for whom the vaccine was not consistent with their religious or personal beliefs (5.85).
Based on our results, we expect that the majority of family medicine physicians and paediatricians in Texas will accept vaccination for COVID-19, and most of those will do so as soon as possible. This finding aligns with other studies that show high acceptance of the vaccine among healthcare workers,26 27 but this study is unique as it focuses specifically on the attitudes of PCPs in the USA. A similar study conducted with general practitioners (n=1623) and primary care nurses (n=1055) in Canada, France and Belgium from October to November 2020 found high levels of COVID-19 vaccine acceptance (74.98%).28 Similarly high levels of participants (79.27%) reported that they would recommend COVID-19 vaccines to their patients. The high level of reported acceptance, coupled with frequent vaccine endorsement, including majority intention to endorse COVID-19 vaccination, is crucial as physician vaccine attitudes and recommendation are vital to patient uptake.10 29 Participants estimated patient and community acceptance at rates similar to those reported in national surveys,3 7 30 yet still not high enough to reach herd immunity or a level of normality.2
At the time of questionnaire dissemination, only the mRNA vaccines (Pfizer-BioNTech and Moderna) were candidates for emergency use authorisation.21 While the majority of participants correctly identified these vaccine types, the novelty of the technology warrants increased physician education show that they can effectively answer patient questions, discuss how the vaccines work and address relevant concerns about safety and efficacy.31 Informed approaches will be especially important as new variants arise, more vaccine types become available and more individuals become eligible for vaccination. In terms of dismissal policies, prior research has shown that most physicians do not endorse dismissing patients who refuse vaccines, though the practice has grown over the last decade and is more prominent among paediatricians than family medicine physicians.32 We report similarly low endorsement of dismissal, though our findings are consistent with the few studies that show that dismissal is used to promote clinical safety and reduce disease risk for other patients.33 While COVID-19 is highly transmissible, with a rate of reproduction (R0) ranging from 1.9 to 6.5,34 and the effects are potentially life threatening, our study suggests that physicians may feel a duty to provide care to their patients and a willingness to assume risks associated with unvaccinated patients.
Our study identified physician self-reported confidence at high levels to respond to specific patient concerns about COVID-19 vaccination. Participants indicated that they felt most confident in situations related to educating patients where factual information might be used to address patient concerns. Specifically, most participants felt confident providing general information about the vaccines and discussing the safety and necessity of vaccination. PCPs and other healthcare professionals have been identified as trustworthy sources of COVID-19 information7 and may be the best situated group to counter misinformation that could dissuade patients from accepting vaccination. A 2021 study of 5 years of Medicare data (2012–2017) found that PCPs provide the most vaccines in the USA,35 which supports that they are both experienced and well equipped to provide COVID-19 vaccinations, immunisation counselling and ongoing clinical guidance to patients. However, others have noted that COVID-19 vaccinations in the USA have mainly been occurring outside of primary care settings, and thus, to encourage the vaccine hesitant to receive the COVID-19 vaccine, vaccination efforts may need to be shifted to primary care in order to take advantage of the trust the PCPs have built with their patients.36
Participants reported that they felt the least confident in responding to patients’ personal or religious objections. In this study, the majority of participants self-identified as having some type of religious affiliation, most commonly a Christian denomination. We did not collect data on the religious preferences or affiliations of participants’ patients, but according to the Pew Research Center, 77% of adult Texans identify as Christian.37 Thus, while there is ongoing debate within the medical and ethical literature about the role of physicians’ spirituality in the practice of medicine,38 it is possible some physicians may choose to have discussions about religion and its impact on vaccine decisions with their patients. However, it is unknown whether comfort level in having such discussions varies by the religion of the physician and patient.
PCPs are ideally situated to deliver guidance and messaging on COVID-19 vaccination. It is important to note that in general PCPs are given little or no training on how to manage discussion of controversial topics with their patients.18 Therefore, providing training on how to address COVID-19 vaccine hesitancy or controversial topics in general may be beneficial to increase vaccination rates. To this end, PCPs may benefit from assistance from professional associations, medical institutions and local governments who provide factual information that they can provide to patients who are considering whether to accept the vaccine. Possible reasons for refusal will likely be diverse and vary by region of the USA, which may necessitate tailored messaging and thoughtful discussions. PCPs should emphasise the benefits of vaccination, including the ability to travel, visit loved ones in nursing homes and achieve a return to normalcy. Messaging should be adapted to physician comfort level, local contexts and patient factors in order to successfully impact vaccine uptake.
While this study provides timely data on physician’s expectations for the COVID-19 vaccine, our sample was only conducted in one state and with just family medicine physicians and paediatricians, and thus the findings may not be generalisable to other physicians practising in other states. It is also possible that there are factors not addressed in this questionnaire that may impact vaccination uptake. The response rate for this questionnaire is also a significant limitation that could potentially hamper the generalisability of our findings, though we do report data from a variety of practice types and settings. Due to the low response rate, it is possible that response biases (ie, recall bias and social desirability bias) may have skewed the results of our sample and may not represent the population of PCPs in Texas. Furthermore, the rate of vaccine acceptance responses and endorsements could also be skewed by physicians’ desire to report socially and scientifically accepted positions on vaccinations. Finally, given the method of sampling and the lack of data on actual vaccination behaviours (eg, COVID-19 vaccination status of participants or patients) follow-up studies are warranted to determine the vaccination uptake by PCPs and their patients in Texas. Nevertheless, the novelty of our findings and the role that they could play in future studies or in the development of messaging for patients should be balanced against the low rate of questionnaire return. The questionnaire and the questions contained within it were developed specifically this study and were created to address issues that were important to the study investigators. Thus, the questionnaire is not validated and may not be generalisable to other study populations.
These data can be used to assist in the development of targeted messaging aimed at improving vaccine uptake and advancing the public health goal of minimising disease and achieving a return to normality. With additional education, support and shifting COVID-19 vaccinations into primary care setting, PCPs can use the trust they have built with their patients to address vaccine hesitancy in their patients. Governments, institutions and medical associations should provide PCPs with the resources needed to respond to patient vaccine hesitancy and to increase vaccine confidence and uptake of COVID-19 vaccination.
We surveyed PCPs in the state of Texas to assess their acceptance of COVID-19 vaccination and their perceptions of patient and community acceptance. The vast majority of the PCPs surveyed stated that they would receive the COVID-19 vaccination when it was available to them and were able to correctly identify the type of vaccines available. We found that PCP confidence to respond to patient concerns about COVID-19 vaccines was fairly high for all of the patient concerns identified. Finally, the PCPs in our study stated they would not dismiss a patient despite not receiving the COVID-19 vaccine, which suggests a commitment to the needs of all patients, including those who choose not to get the vaccine.
Data availability statement
No data are available.
Patient consent for publication
This study was approved as an exempt study by UT Southwestern Medical Center's Institutional Review Board (STU:2020–1022) to conduct the current study using human subjects, and a waiver of consenting procedures was granted.
We would like to acknowledge Kathy McCarthy of the Texas Academy of Family Physicians and Tricia Hall of the Texas Pediatric Society who helped facilitate the questionnaire dissemination. We would also like to acknowledge Cathy Day for her assistance in importing the questionnaire into
Research Electronic Data Capture.
Contributors PD is credited with substantial contribution to the design of the overall work, including reviewing relevant literature to create the study questionnaire, creating the questionnaire, identifying the means of questionnaire dissemination, coordinating dissemination and receipt of study data, interpreting the results, writing the first draft of the manuscript, approving revisions to the manuscript, final approval of the version to be published and agreement of accountability for all aspects of the work. CS is credited with significant contribution to the overall work, reviewing relevant literature, performing all statistical analysis, constructing and designing data tables, reviewing first and final drafts, providing significant revisions to the version to be published and agreement of accountability for all aspects of the work. NK and FDS are credited with providing substantial interpretation of the data from a clinical perspective, reviewing and approving included elements of the questionnaire, assisting in the dissemination of the questionnaire, reviewing and approving the first and final drafts, approval of the version to be published and agreement of accountability for all aspects of the work. EMA is credited with significant contribution to the study design, reviewing the initial and final versions of the work, the revision of critically important intellectual content, reviewing relevant literature, overseeing the statistical analysis and agreement of accountability for all aspects of the work. PD is the guarantor of the manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.